These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7391935)

  • 1. High-performance liquid chromatographic determination of epimers, impurities, and content of the glucocorticoid budesonide and preparation of primary standard.
    Roth G; Wikby A; Nilsson L; Thalén A
    J Pharm Sci; 1980 Jul; 69(7):766-70. PubMed ID: 7391935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of epimers 22R and 22S of budesonide in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
    Li YN; Tattam B; Brown KF; Seale JP
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):259-68. PubMed ID: 8891924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous quantification of 22R and 22S epimers of budesonide in human plasma by ultra-high-performance liquid chromatography-tandem mass spectrometry: application in a stereoselective pharmacokinetic study.
    Lu Y; Sun Z; Zhang Y; Chen X; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():27-34. PubMed ID: 23416292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the epimeric glucocorticoid budesonide.
    Ryrfeldt A; Edsbäcker S; Pauwels R
    Clin Pharmacol Ther; 1984 Apr; 35(4):525-30. PubMed ID: 6705451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic method for the determination of budesonide in bronchoalveolar lavage of asthmatic patients.
    Faouzi MA; Dine T; Luyckx M; Brunet C; Gressier B; Cazin M; Wallaert B; Cazin JC
    J Chromatogr B Biomed Appl; 1995 Feb; 664(2):463-7. PubMed ID: 7780604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous Determination of Formoterol Fumarate and Budesonide Epimers in Metered Dose Inhaler Using Ion-Pair Chromatography.
    Salem YA; Shaldam MA; El-Sherbiny DT; El-Wasseef DR; El-Ashry SM
    J Chromatogr Sci; 2017 Nov; 55(10):1013-1020. PubMed ID: 28977479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A stability-indicating HPLC assay method for budesonide.
    Hou S; Hindle M; Byron PR
    J Pharm Biomed Anal; 2001 Jan; 24(3):371-80. PubMed ID: 11199216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a high-performance liquid chromatographic method for the analysis of budesonide.
    Gupta M; Bhargava HN
    J Pharm Biomed Anal; 2006 Feb; 40(2):423-8. PubMed ID: 16143482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct separation, identification and quantification of epimers 22R and 22S of budesonide by capillary gas chromatography on a short analytical column with Rtx-5 stationary phase.
    Krzek J; Czekaj JS; Rzeszutko W; Jończyk A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):191-200. PubMed ID: 15063325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Quantification by NMR Spectroscopy of the 22
    Kuz'mina NE; Moiseev SV; Severinova EY; Stepanov EA; Bunyatyan ND
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
    J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epimers of budesonide and related corticosteroids. III. Synthesis and structure elucidation by carbon-13 and proton nuclear magnetic resonance spectroscopy.
    Thalén A
    Acta Pharm Suec; 1987; 24(3):97-114. PubMed ID: 3687472
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of (22R,S)budesonide in human plasma by automated liquid chromatography/thermospray mass spectrometry.
    Lindberg C; Blomqvist A; Paulson J
    Biol Mass Spectrom; 1992 Nov; 21(11):525-33. PubMed ID: 1457467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic studies of a potent glucocorticoid (budesonide) in dogs by high-performance liquid chromatography.
    Ryrfeldt A; Tönnesson M; Nilsson E; Wikby A
    J Steroid Biochem; 1979 Mar; 10(3):317-24. PubMed ID: 459494
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
    Dahlberg E; Thalén A; Brattsand R; Gustafsson JA; Johansson U; Roempke K; Saartok T
    Mol Pharmacol; 1984 Jan; 25(1):70-8. PubMed ID: 6708937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation in vitro of the 22R and 22S epimers of budesonide by human liver, bronchus, colonic mucosa and skin.
    Cortijo J; Urbieta E; Bort R; Castell JV; Ruiz-Bravo C; Martinez J; Palacios-Pelaez R; Lledó S; Morcillo EJ
    Fundam Clin Pharmacol; 2001 Feb; 15(1):47-54. PubMed ID: 11468013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high performance liquid chromatographic system for the analysis of tetracycline drug standards, analogs, degradation products and other impurities.
    Mack GD; Ashworth RB
    J Chromatogr Sci; 1978 Mar; 16(3):93-101. PubMed ID: 641134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using total error concept for the validation of a liquid chromatography-tandem mass spectrometry method for the determination of budesonide epimers in human plasma.
    Streel B; Cahay B; Klinkenberg R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2290-300. PubMed ID: 19249257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective determination of potential impurities in an active pharmaceutical ingredient using HPLC-SPE-HPLC.
    Yamamoto E; Niijima J; Asakawa N
    J Pharm Biomed Anal; 2013 Oct; 84():41-7. PubMed ID: 23806999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.